跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diovac - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diovac
Approved
STANDARD
Diovac
Standard Chemical and Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e64a87890232f29a
Company
Standard Chemical and Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
e64a87890232f29a
Drug Approval Philippines Name
Diovac
Product Name
Diovac
Registration Number
DR-XY42374
Brand Name
Diovac
Generic Name
Valsartan
Dosage Form
Film-Coated Tablet
Dosage Strength
160 mg
Manufacturer
Standard Chemical and Pharmaceutical Co., Ltd.
Importer
Phil Pharmawealth, Inc.
Distributor
Phil Pharmawealth, Inc.
Issuance Date
29 July 2023
Expiry Date
06 August 2028
Pharmacologic Category
Angiotensin-2-Receptor Blocker (ARB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e64a87890232f29a
Type
Standard
Back to Philippines FDA Approvals